Folate in depression: Efficacy, safety, differences in formulations, and clinical issues

Journal of Clinical Psychiatry

Volumn 70, Issue SUPPL. 5, 2009, Pages 12-17

  Fava, Maurizio ^a   Mischoulon, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; AMITRIPTYLINE; DIHYDROFOLATE REDUCTASE; DOPAMINE; FLUOXETINE; FOLIC ACID; FOLINIC ACID; HOMOCYSTEINE; LAMOTRIGINE; LITHIUM; NORADRENALIN; PLACEBO; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

ABSENCE OF SIDE EFFECTS; ADJUVANT THERAPY; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR DEPRESSION; BLURRED VISION; CANCER RISK; CLINICAL TRIAL; COGNITION; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; VERTIGO; VISUAL ANALOG SCALE; WELLBEING;

AGED; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS AS TOPIC; DEMENTIA; DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; DOSAGE FORMS; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; HUMANS; LEUCOVORIN; MALE; TETRAHYDROFOLATES; TREATMENT OUTCOME;

EID: 72749125429     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.8157su1c.03     Document Type: Article

References (28)

1. Alpert JE, Fava M. Nutrition and depression: the role of folate. Nutr Rev. 1997;55(5):145-149. PubMed
2. Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, pt 1: predictors of clinical response in fluoxetine-resistant depression. J Clin Psychiatry. 2004;65(8):1090-1095. PubMed
3. Papakostas GI, Petersen T, Mischoulon D, et al. Serum folate, vitamin B12, and homocysteine in major depressive disorder, pt 2: predictors of relapse during the continuation phase of pharmacotherapy. J Clin Psychiatry. 2004;65(8):1096-1098. PubMed
4. Ramos MI, Allen LH, Mungas DM, et al. Low folate status is associated with impaired cognitive function and dementia in the Sacramento Area Latino Study on Aging. Am J Clin Nutr. 2005;82(6):1346-1352. PubMed
5. Fava M, Graves LM, Benazzi F, et al. A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry. 2006;67(11):1754-1758. PubMed
6. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. PubMed doi:10.1176/appi.ajp.163.1.28
7. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry. 1999;60(4):221-225. PubMed
8. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry. 2006;59(11):1052-1060. PubMed doi:10.1016/j.biopsych.2006.01. 016 (Pubitemid 43849658)
9. Fava M, Rush AJ. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychother Psychosom. 2006;75(3):139-153. PubMed doi:10.1159/000091771
10. Berlanga C, Ortega-Soto HA, Ontiveros M, et al. Efficacy of S-adenosyl-L-methionine in speeding the onset of action of imipramine. Psychiatry Res. 1992;44(3):257-262. PubMed doi:10.1016/0165-1781(92)90029-3 (Pubitemid 23036978)
11. National Institutes of Health Office of Dietary Supplements. Dietary Supplement Fact Sheet: Folate. http://ods.od.nih.gov/factsheets/Folate-pf.asp. April 15, 2009. Accessed July 17, 2009.
12. Farah A. The role of L-methylfolate in depressive disorders. CNS Spectr. 2009;14(suppl 2):1-7.
13. Miller AL. The methylation, neurotransmitter, and antioxidant connections between folate and depression. Altern Med Rev. 2008;13(3):216-226. PubMed
14. Shelton RC. The role of L-methylfolate in depressive disorders: commentary. CNS Spectr. 2009;14:1(suppl 2):8.
15. Kelly CB, McDonnell AP, Johnston TG, et al. The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J Psychopharmacol. 2004;18(4):567-571. PubMed doi:10.1177/0269881104047285
16. Coppen A, Chaudhry SSC. Folic acid enhances lithium prophylaxis. J Affect Disord. 1986;10(1):9-13. PubMed doi:10.1016/0165-0327(86)90043-1
17. Coppen A, Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomized, placebo controlled trial. J Affect Disord. 2000;60(2):121-130. PubMed doi:10.1016/S0165-0327(00)00153-1
18. Godfrey PSA, Toone BK, Carney MWP, et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet. 1990;336(8712):392-395. PubMed doi:10.1016/0140-6736(90)91942-4
19. Crellin R, Bottiglieri T, Reynolds EH. Folates and psychiatric disorders: clinical potential. Drugs. 1993;45(5):623-636. PubMed doi:10.2165/00003495- 199345050-00001
20. Passeri M, Cucinotta D, Abate G, et al. Oral 5R-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging (Milano). 1993;5(1):63-71. PubMed (Pubitemid 23117911)
21. Guaraldi GP, Fava M, Mazzi F, et al. An open trial of methyltetrahydrofolate in elderly depressed patients. Ann Clin Psychiatry. 1993;5(2):101-105. PubMed doi:10.3109/10401239309148970
22. Di Palma C, Urani R, Agricola R, et al. Is methylfolate effective in relieving major depression in chronic alcoholics? A hypothesis of treatment. Curr Ther Res. 1994;55(5):559-567. doi:10.1016/S0011-393X(05)80187-0
23. Alpert JE, Mischoulon D, Rubenstein GE, et al. Folinic acid (leucovorin) as an adjunctive treatment for SSRI-refractory depression. Ann Clin Psychiatry. 2002;14(1):33-38. PubMed (Pubitemid 34538830)
24. Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;(4):CD004514. PubMed
25. McMahon JA, Green TJ, Skeaff M, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354(26):2764-2772. PubMed doi:10.1056/NEJMoa054025
26. Frankenburg FR, Folate supplementation: is it safe and effective? (letter) J Clin Psychiatry. 2009;70(5):767; author reply 767-769. PubMed doi:10.4088/JCP.08lr04824
27. Stahl SM. l-Methylfolate: a vitamin for your monoamines. J Clin Psychiatry. 2008;69(9):1352-1353. PubMed doi:10.4088/JCP.v69n0901
28. Mischoulon D, Fava M. Are nutritional supplements ready for prime time? J Clin Psychiatry. 2008;69(9):1497-1498. PubMed doi:10.4088/JCP.v69n0918